Total Revenue: $9.6 million in Q4 2024, up 10% from $8.7 million in Q4 2023.Global Net Recurring Revenue: $5.8 million in Q4 2024, compared to $5.6 million in
HORSHAM, Pa., March 21, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (”STRATA” or the ”Company”) ( SSKN), a medical technology company dedicate
HORSHAM, Pa., March 20, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (”STRATA” or the ”Company”) ( SSKN), a medical technology company dedicate
Strata Skin Sciences (SSKN) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
HORSHAM, Pa., Dec. 05, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (”STRATA” or the ”Company”) ( SSKN), a medical technology company dedicated
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Strata Skin Sciences (SSKN) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
HORSHAM, Pa., Sept. 05, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company...
Total Revenue: $8.4 million, up 2% year-over-year.Total Operating Expenses: Declined by $850,000 or 14% year-over-year.Loss from Operations: Reduced by $1.5 mi
Aug 14, 2024 / 08:30PM GMTOperator Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the STRATA Skin Sciences, Inc., Second Quarte
Loading... Loading...
Shares of Clever Leaves Holdings Inc. CLVR fell sharply during Monday's session after the company announced that it will voluntarily deli...
The global dermatology excimer laser market was valued at USD 429.11 million in 2021 and is predicted to reach at USD 1040.32 million by 2030, increasing...
EscharEx® Phase III study protocol: FDA/EMA-aligned; patient enrollment commencing early 2024; two key research collaborations with wound industry leaders NexoBrid® U.S. commercial launch...
-Today at 04:04 pm- MarketScreener
/PRNewswire/ -- The "Global Energy-based Aesthetic Devices Market Size and Share Analysis by Technology, Application, Distribution Channel, End-user - Forecast...